Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency

Mostrar otras versiones (1)

Myeloid sarcoma (MS) carries a poor prognosis, and information on epigenetic modifications in MS is currently limited. In the present study, 214 ten-eleven translocation-2 (TET2)(−/−) mice were successfully constructed. In addition, 436 patients with myelodysplastic syndrome (MDS) and 354 with acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinhuan, Miao, Zhaoyi, Jiang, Yanan, Zou, Ping, Li, Weiming, Tang, Xiaoqiong, Lv, Yangyang, Xing, Donghui, Chen, Shi, Yang, Fengchun, Xu, Mingjiang, Cao, Zeng, Wang, Haitao, Zhao, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202316/
https://www.ncbi.nlm.nih.gov/pubmed/32382331
http://dx.doi.org/10.3892/ol.2020.11479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202316/
https://www.ncbi.nlm.nih.gov/pubmed/32382331
http://dx.doi.org/10.3892/ol.2020.11479

Ejemplares similares